Received Aug 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z003309 | — |
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of improperly stored PROQUAD. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered following the excursion. HCP reported; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-Jul-2025, the patient was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z003309, expiration date: 21-Jul-2026) 0.5 mL, for prophylaxis, diluted with sterile diluent (MERCK STERILE DILUENT), 0.5 mL (indication, expiration date, and lot # were not reported). Temperature excursion occurred at 52.2 F; timeframe was unknown (Product storage error). No symptoms or side effects were reported.
sterile diluent